Cargando…

The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases

Purpose. The aim of this study is to investigate the reliability of diffusion MRI for detection of cancer foci by comparing diffusion-weighted imaging (DWI) results and pathology results of prostate biopsy sites. Methods. Of the patients who applied with lower urinary tract symptoms, 36 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilinç, R., Doluoglu, O. G., Sakman, B., Ciliz, D. S., Yüksel, E., Adsan, O., Cetinkaya, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390046/
https://www.ncbi.nlm.nih.gov/pubmed/22792487
http://dx.doi.org/10.5402/2012/252846
_version_ 1782237389395066880
author Kilinç, R.
Doluoglu, O. G.
Sakman, B.
Ciliz, D. S.
Yüksel, E.
Adsan, O.
Cetinkaya, M.
author_facet Kilinç, R.
Doluoglu, O. G.
Sakman, B.
Ciliz, D. S.
Yüksel, E.
Adsan, O.
Cetinkaya, M.
author_sort Kilinç, R.
collection PubMed
description Purpose. The aim of this study is to investigate the reliability of diffusion MRI for detection of cancer foci by comparing diffusion-weighted imaging (DWI) results and pathology results of prostate biopsy sites. Methods. Of the patients who applied with lower urinary tract symptoms, 36 patients who had suspected DRE and/or PSA ≥2.5 ng/mL were included in the study. Patients underwent DWI prior to 10 cores-prostate biopsy. 356 biopsy cores were obtained from the patients. Foci from the patients with prostate cancer were labeled as malignant or benign foci, likewise foci from the patients with benign pathology were grouped as BPH and inflammation foci. Apparent diffusion coefficients (ADCs) of biopsy groups were compared with each other in order to measure the reliability of DWI in detection of PCa foci. Results. When ADC values of adenocarcinoma foci and BPH foci were compared, a statistically significant difference was found (P < 0.001). When ADC values obtained from adenocarcinoma foci and chronic inflammation foci are compared, the difference between two groups is statistically significant, too (P < 0.001). Conclusions. Biopsies focused on suspected regions after formation of ADC maps by means of DWI would provide to start definitive treatment immediately as well as being beneficial to prevent morbidity related to repeated prostate biopsies.
format Online
Article
Text
id pubmed-3390046
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-33900462012-07-12 The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases Kilinç, R. Doluoglu, O. G. Sakman, B. Ciliz, D. S. Yüksel, E. Adsan, O. Cetinkaya, M. ISRN Urol Clinical Study Purpose. The aim of this study is to investigate the reliability of diffusion MRI for detection of cancer foci by comparing diffusion-weighted imaging (DWI) results and pathology results of prostate biopsy sites. Methods. Of the patients who applied with lower urinary tract symptoms, 36 patients who had suspected DRE and/or PSA ≥2.5 ng/mL were included in the study. Patients underwent DWI prior to 10 cores-prostate biopsy. 356 biopsy cores were obtained from the patients. Foci from the patients with prostate cancer were labeled as malignant or benign foci, likewise foci from the patients with benign pathology were grouped as BPH and inflammation foci. Apparent diffusion coefficients (ADCs) of biopsy groups were compared with each other in order to measure the reliability of DWI in detection of PCa foci. Results. When ADC values of adenocarcinoma foci and BPH foci were compared, a statistically significant difference was found (P < 0.001). When ADC values obtained from adenocarcinoma foci and chronic inflammation foci are compared, the difference between two groups is statistically significant, too (P < 0.001). Conclusions. Biopsies focused on suspected regions after formation of ADC maps by means of DWI would provide to start definitive treatment immediately as well as being beneficial to prevent morbidity related to repeated prostate biopsies. International Scholarly Research Network 2012-06-26 /pmc/articles/PMC3390046/ /pubmed/22792487 http://dx.doi.org/10.5402/2012/252846 Text en Copyright © 2012 R. Kilinç et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Kilinç, R.
Doluoglu, O. G.
Sakman, B.
Ciliz, D. S.
Yüksel, E.
Adsan, O.
Cetinkaya, M.
The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title_full The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title_fullStr The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title_full_unstemmed The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title_short The Correlation between Diffusion-Weighted Imaging and Histopathological Evaluation of 356 Prostate Biopsy Sites in Patients with Prostatic Diseases
title_sort correlation between diffusion-weighted imaging and histopathological evaluation of 356 prostate biopsy sites in patients with prostatic diseases
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390046/
https://www.ncbi.nlm.nih.gov/pubmed/22792487
http://dx.doi.org/10.5402/2012/252846
work_keys_str_mv AT kilincr thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT doluogluog thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT sakmanb thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT cilizds thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT yuksele thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT adsano thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT cetinkayam thecorrelationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT kilincr correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT doluogluog correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT sakmanb correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT cilizds correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT yuksele correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT adsano correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases
AT cetinkayam correlationbetweendiffusionweightedimagingandhistopathologicalevaluationof356prostatebiopsysitesinpatientswithprostaticdiseases